Early Access — free while we kick the tires
EdgarHawk

BAIN CAPITAL INVESTORS LLC

10% Owner

10% Owner

Latest: Insider buying · April 2026

6 filings analyzed · 4 companies · Latest 2026-04-20

Companies

Company Buys Sells Direction
Kailera Therapeutics, Inc. KLRA 2 0 Net buying
Bob's Discount Furniture, Inc. BOBS 0 1 Net selling
COHERENT CORP. COHR 0 3 Net selling
Waystar Holding Corp. WAY 0 7 Net selling

Activity

April 2026
high
Buy
8,398,438 shares
$134,375,008
Significance 8/10

Bain Capital Investors LLC buys 8,398,438 shares of KLRA at $16.00 for $134.4M, raising stake to 26.26M shares; cluster buy by 4 other insiders in 14 days

Bain Capital Investors LLC, a 10% owner, purchased 8,398,438 shares at $16.00 on 2026-04-20, expanding its stake by 47.0% to 26,255,581 shares post-transaction, just two trading days after KLRA's recent listing. Notably, 4 other insiders also bought within the past 14 days, establishing a cluster buy pattern. While the current market price of $24.61 reflects a 53.8% premium over the transaction price of $16.00, the stock is newly listed and traditional valuation anchors (52-week metrics) are not yet meaningful. This concentration of insider purchases across multiple parties shortly after IPO warrants investor scrutiny of the underlying transaction rationale and whether coordinated buying reflects confidence in near-term fundamentals or capital deployment tied to the listing mechanics.

February 2026
Sell
2,917,500 shares
$46,497,656
Significance 6/10

Bain Capital sells 2,917,500 BOBS shares at $15.94; stock now at $20.08 post-IPO

Bain Capital Investors LLC, a 10% owner, sold 2,917,500 shares at $15.94 on 2026-02-13, reducing its stake from 98,288,251 shares to 95,370,751 shares (-3.0% of pre-transaction holdings). The sale occurred just 7 trading days after Bob's Discount Furniture's listing, at a price $4.14 below the current market price of $20.08. This early-stage post-IPO sale by a significant institutional anchor investor during the stabilization period is noteworthy; the discount to current price suggests the transaction may have been part of a structured exit or lock-up-period management rather than a discretionary opportunistic trade. Investors should monitor whether additional selling follows as Bain continues to unwind its position in the newly public company.

November 2025
2025-11-12 COHERENT CORP. COHR
high
Sell
7,500,000 shares
$1,075,275,000
Significance 6/10

Bain Capital Investors sells 7,500,000 COHR shares at $143.37; stock rose 36.1% in 30 days post-transaction.

Bain Capital Investors LLC, a 10% shareholder, executed a sale of 7,500,000 shares at $143.37 on 2025-11-07 for $1.1B in total value. The sale eliminated the investor's entire common equity position (7,500,000 shares pre-transaction, 0 post-transaction), though the FLAG notation indicates derivative securities may remain in Table II, suggesting this is a conversion or partial liquidation of one security class rather than a complete exit. Post-transaction, COHR stock has appreciated 36.1% over 30 days and 70.9% over 90 days to a current price of $156.67, indicating the sale was poorly timed relative to subsequent price appreciation. Within Bain Capital's cross-ticker track record, sells have averaged a 75.00% well-timed rate (meaning 75% of prior sells preceded stock declines), but this transaction has moved in the opposite direction, suggesting either a shift in conviction or a structural event unrelated to equity market timing.

September 2025
high
Sell
4,295,139 shares
$168,412,400
Significance 6/10

Bain Capital Investors LLC (10% owner) sold 4,295,139 shares of WAY at $39.21 for $168.4M on 2025-09-12, reducing stake by 24.5%.

Bain Capital liquidated nearly a quarter of its Waystar holding, offloading 4,295,139 shares at $39.21. The 24.5% reduction in position size represents a material reallocation by a significant 10% shareholder, with proceeds of $168.4M. At the same-ticker level, Bain's prior three WAY sales (Feb 2025, May 2025 ×2) showed mixed 90-day outcomes: two of three were well-timed against subsequent declines. The current $38.25 price sits 15.7% below the 52-week high but 6.0% above the 30-day moving average. Waystar's valuation backdrop shows a 78.06 P/E, elevated revenue growth of +19.3% year-over-year, yet full-year profitability remains negative despite positive recent quarterly earnings of $32.2M on $270.7M revenue—a composition that may warrant scrutiny of underlying earnings sustainability at this valuation multiple.

May 2025
high
Sell
3,464,090 shares
$129,522,325
Significance 6/10

Bain Capital Investors LLC sells 3,464,090 shares (3.46M) of WAY at $37.39 for $129,522,325.10 across two dates

Bain Capital Investors LLC, a 10% stakeholder, executed two separate sales totaling 3,464,090 shares for $129,522,325.10, reducing holdings by 16.1% from 21,519,139 to 18,055,049 shares. The transactions occurred on 2025-05-16 and 2025-05-20 at a blended average price of $37.39, which is below the current price of $39.65 and 12.6% below the 52-week high of $45.35. The fundamental picture is mixed: revenue grew 19.3% annually to $256,435,000.00, but the company remains unprofitable on a full-year basis with a P/E ratio of 264.33, indicating the market is pricing in significant future growth expectations. The timing of this substantial reduction in a strategic ownership stake warrants attention given the stock's recent 8.8% gain over 30 days and the company's elevated valuation multiples despite current-year losses.

February 2025
high
Sell
5,652,689 shares
$218,193,795
Significance 7/10

Bain Capital Investors LLC sold 5,652,689 shares (21.8% of stake) of WAY at $38.60 for $218.2M on 2025-02-24

Bain Capital Investors LLC, a 10% owner, executed a substantial sale of 5,652,689 shares at $38.60, reducing its holdings from 27,407,225 to 21,754,536 shares and liquidating approximately $218.2M in WAY equity. The transaction occurred at a price $3.75 below the current market price of $42.35, suggesting the insider did not fully capture recent upside; the stock has appreciated 9.8% over the preceding 30 days and 38.4% over 90 days. Notably, the company remains unprofitable on a full-year basis despite strong revenue growth of 19.3% and a recent quarterly net income of $5.4M, creating tension between top-line momentum and bottom-line weakness. Bain's own cross-ticker track record shows a 100% well-timed rate on prior sales (avg 90d return: -17.7%), but this specific transaction's post-sale stock performance—occurring after significant recent gains—will be the material test of execution at this ticker.

Related insiders

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access